Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study - PubMed

Among pediatric AD patients, dupilumab was associated with reduced risk of atopic march progression compared with conventional therapies.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov